IL10 and COVID-19: Interestingly, this peculiar B cell dynamics was also observed in autoimmune pathologies characterized by chronic inflammation (97), while the resolution of lung pathology in COVID-19 patients was found to be associated with higher proportions of IL-10+ B cells, suggesting that these cells could be important in suppressing excess inflammation and positive long-term outcomes (77).